Weekly Recap | Moderna -1.09%, tumour vaccine milestoneWeekly Review·Sep 12 at 06:22 AMMRNA+1.29%MRNY+1.51%
Weekly Recap | Moderna +5.48%, consensus target below spotWeekly Review·Sep 5 at 07:36 AMMRNA+1.29%MRNY+1.51%
Weekly Recap | Moderna -4.92%, convertible offering weighsWeekly Review·Aug 29 at 06:02 AMMRNA+1.29%MRNY+1.51%
